CBD in the Treatment of PTSD, Alzheimers, Addiction and Mood Disorders
Dr. Dawn-Elise Snipes is a Licensed Professional Counselor and Qualified Clinical Supervisor. She received her PhD in Mental Health Counseling from the University of Florida in 2002. In addition to being a practicing clinician, she has provided training to counselors, social workers, nurses and case managers internationally since 2006 through AllCEUs.com 📢SUBSCRIBE and click the BELL to get notified when new videos are uploaded.
💲 Unlimited CEUs $59 based on these videos at allceus.com for social work, counseling, marriage and family therapy, addiction counseling, case management, pastoral counseling and more.
👋 Chat with me at https://members.docsnipes.com/ For $10/month where you get access to my tips for health and wellness and you can text chat with me privately 7 days a week.
#CBD #PTSDtreatment #EndAlz #cheapceus
CBD in the Treatment of PTSD, Alzheimers, Addiction and Mood Disorders
Neuroprotective potential of CBD, based on the combination of its anti-inflammatory and anti-oxidant properties, presently under investigation in numerous neurodegenerative disorder including AD, PD and HD
Previous clinical studies using CBD concentrated on symptom relief in HD rather than on disease progression and did not show any significant improvement
Regarding PD, activation of CB1 receptors (via THC) enhances rather motor disability; however, CBD acts independently of those receptors
major efforts are being directed at finding cannabinoid molecules that provide neuroprotection through their anti-oxidant properties and activate CB2 but not CB1 receptors
Oral CBD in addition to routine psychiatric care was associated with PTSD symptom reduction in adults
CBD also appeared to offer relief from frequent nightmares as a symptom of their PTSD.
CBD seems to blunt the rewarding properties of many drugs (including THC)
Clinical trials currently focus on CBD for people addicted to opioids or cocaine
Animal studies find that CBD reduces the overall level of alcohol intake,